Related references
Note: Only part of the references are listed.A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer
Jiayang Liu et al.
FRONTIERS IN IMMUNOLOGY (2022)
An engineered IL-21 with half-life extension enhances anti-tumor immunity as a monotherapy or in combination with PD-1 or TIGIT blockade
Hongchuan Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability
Xingzhe Ma et al.
CELL METABOLISM (2021)
Immune Checkpoint Inhibitor-Based Strategies for Synergistic Cancer Therapy
Mengying He et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Potentiating CD8+ T cell antitumor activity by inhibiting PCSK9 to promote LDLR-mediated TCR recycling and signaling
Juanjuan Yuan et al.
PROTEIN & CELL (2021)
TGF beta 1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism
Stefania Cane et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
PCSK9 regulates the NODAL signaling pathway and cellular proliferation in hiPSCs
Meryl Roudaut et al.
STEM CELL REPORTS (2021)
PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma
Shi-Zhe Zhang et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)
Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors
Shihao Xu et al.
IMMUNITY (2021)
PCSK9 Biology and Its Role in Atherothrombosis
Cristina Barale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The cutting-edge progress of immune-checkpoint blockade in lung cancer
Fei Zhou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Haiping Wang et al.
NATURE IMMUNOLOGY (2020)
The Tumor Microenvironment in the Response to Immune Checkpoint Blockade Therapies
Florent Petitprez et al.
FRONTIERS IN IMMUNOLOGY (2020)
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
Jackie E. Bader et al.
MOLECULAR CELL (2020)
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
Gregoire de Streel et al.
NATURE COMMUNICATIONS (2020)
Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity
Alison E. Ringel et al.
CELL (2020)
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
Xinjian Liu et al.
NATURE (2020)
α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by -TGF antibody to promote durable rejection and immunity in squamous cell carcinomas
E. Dodagatta-Marri et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8+ T Cell-Derived Interferon-γ
Chang Liu et al.
IMMUNITY (2019)
Immune Checkpoint Inhibitor Toxicities
Julian A. Marin-Acevedo et al.
MAYO CLINIC PROCEEDINGS (2019)
Treg-mediated acquired resistance to immune checkpoint inhibitors
Reem Saleh et al.
CANCER LETTERS (2019)
Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy
Hao Liu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
CD36 tango in cancer: signaling pathways and functions
Jingchun Wang et al.
THERANOSTICS (2019)
Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma
Xuyao Zhang et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
Tomasz Maj et al.
NATURE IMMUNOLOGY (2017)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)